Aquestive Therapeutics Ownership | Who Owns Aquestive Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Aquestive Therapeutics Ownership Summary

Aquestive Therapeutics is owned by 11.10% institutional investors, 2.97% insiders, and 85.93% retail investors. Bratton capital management is the largest institutional shareholder, holding 8.04% of AQST shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.65% of its assets in Aquestive Therapeutics shares.

AQST Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Aquestive Therapeutics	11.10%	2.97%	85.93%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Specialty & Generic Drug Manufacturers Stocks	20.67%	13.90%	65.43%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bratton capital management	9.81M	8.04%	$40.72M
Blackrock	5.45M	7.41%	$14.18M
Blackrock funding, inc. /de	7.51M	6.16%	$31.16M
Rtw investments, lp	7.43M	6.09%	$30.82M
Vanguard group	5.89M	5.33%	$38.06M
Federated hermes	2.94M	2.41%	$12.20M
Balyasny asset management	2.90M	2.38%	$12.04M
State street	2.55M	2.09%	$10.57M
Samsara biocapital	2.50M	2.05%	$10.38M
Geode capital management	2.41M	1.97%	$10.00M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bratton capital management	9.81M	100.00%	$40.72M
Propel bio management	710.99K	1.86%	$2.95M
Blue owl capital lp	1.35M	1.50%	$5.59M
Everstar asset management	553.18K	1.22%	$2.30M
Sio capital management	1.92M	1.14%	$7.98M
Samsara biocapital	2.50M	1.01%	$10.38M
Latash investments	243.13K	0.78%	$1.01M
Rosalind advisors	250.00K	0.42%	$1.04M
Harvey capital management	343.75K	0.41%	$1.92M
Diametric capital, lp	335.44K	0.36%	$1.39M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	5.45M	0.00%	4.11M
Balyasny asset management	2.90M	0.02%	1.93M
Rtw investments, lp	7.43M	0.31%	1.18M
Sio capital management	1.92M	1.14%	929.79K
Federated hermes	2.94M	0.02%	907.52K

Top Sellers

Holder	Shares	% Assets	Change
Vr adviser	-	-	-2.63M
Ecor1 capital	-	-	-2.63M
Franklin resources	-	-	-2.13M
Bioimpact capital	-	-	-1.61M
Laurion capital management lp	-	-	-1.55M

New Positions

Holder	Shares	% Assets	Change	Value
Propel bio management	710.99K	1.86%	710.99K	$2.95M
Vanguard fiduciary trust	637.51K	0.00%	637.51K	$2.65M
Point72 asset management	283.73K	0.00%	283.73K	$1.18M
Awm investment company	270.40K	0.12%	270.40K	$1.12M
Rosalind advisors	250.00K	0.42%	250.00K	$1.04M

Sold Out

Holder	Change
National bank of canada /fi/	-4.00
Northwestern mutual wealth management	-4.00
Srs capital advisors	-7.00
Coppell advisory solutions	-16.00
Highmark wealth management	-50.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	86	-54.50%	13,538,137	-81.25%	11	0.26%	48	-60.33%	18	-51.35%
Dec 31, 2025	116	-26.58%	37,857,717	-42.70%	34	0.77%	76	-27.62%	22	-24.14%
Sep 30, 2025	150	36.36%	65,817,254	45.31%	66	3.19%	98	48.48%	28	33.33%
Jun 30, 2025	118	-5.60%	47,569,617	7.50%	47	2.23%	66	-9.59%	26	-13.33%
Mar 31, 2025	125	5.93%	44,252,862	2.02%	46	2.04%	73	8.96%	30	-6.25%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	3.29M	2.65%	-
Vanguard US Total Market Shares ETF	2.40M	2.43%	-
iShares Russell 2000 ETF	2.40M	1.93%	20.26K
Federated Hermes MDT SCC Institutional	1.39M	1.12%	330.84K
Federated Hermes MDT Small Cap Core IS	1.39M	1.12%	330.84K
Invesco Dorsey Wright SmallCap Momt ETF	775.69K	0.85%	1.41K
Vanguard Institutional Extnd Mkt Idx Tr	1.05M	0.84%	5.96K
Fidelity Small Cap Index	1.02M	0.82%	8.56K
Nuveen Equity Index R6	649.35K	0.71%	-
Wasatch Ultra Growth	856.62K	0.69%	186.43K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 15, 2026	Barber Daniel	President and CEO	Sell	$35.41K
Mar 10, 2026	Boyd Peter E.	Chief People Officer	Sell	$124.41K
Mar 10, 2026	Barber Daniel	President and CEO	Sell	$753.97K
Mar 10, 2026	BRAENDER LORI J	Chief Legal Officer	Sell	$167.35K
Mar 10, 2026	Cioffi Melina	SVP, Regulatory Affairs	Sell	$105.62K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	1
2026 Q1	-	7
2025 Q4	-	3
2025 Q3	-	5
2025 Q2	-	-

AQST Ownership FAQ

Who Owns Aquestive Therapeutics?

Aquestive Therapeutics shareholders are primarily institutional investors at 11.10%, followed by 2.97% insiders and 85.93% retail investors. The average institutional ownership in Aquestive Therapeutics's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.67%, which Aquestive Therapeutics falls below.

Who owns the most shares of Aquestive Therapeutics?

Aquestive Therapeutics’s largest shareholders are Bratton capital management (9.81M shares, 8.04%), Blackrock (5.45M shares, 7.41%), and Blackrock funding, inc. /de (7.51M shares, 6.16%). Together, they hold 21.61% of Aquestive Therapeutics’s total shares outstanding.

Does Blackrock own Aquestive Therapeutics?

Yes, BlackRock owns 7.41% of Aquestive Therapeutics, totaling 5.45M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.18M$. In the last quarter, BlackRock increased its holdings by 4.11M shares, a 305.59% change.

Who is Aquestive Therapeutics’s biggest shareholder by percentage of total assets invested?

Bratton capital management is Aquestive Therapeutics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 9.81M Aquestive Therapeutics shares, valued at 40.72M$.

Who is the top mutual fund holder of Aquestive Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aquestive Therapeutics shares, with 2.65% of its total shares outstanding invested in 3.29M Aquestive Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools